mPulse Strengthens Market Position with Health Experience and Insights Leadership in Q1 2025
LOS ANGELES--(BUSINESS WIRE)--mPulse, a leading provider of Health Experience and Insights (HXI) technology, today announced strong Q1 financial performance while concurrently driving momentum focused on improving digital engagement capabilities with its HXI platform, which sees over four billion consumer touch points annually. The company launched key platform enhancements to better enable healthcare organizations to deploy meaningful consumer experiences and successfully advocated for improved healthcare regulations that benefit the broader healthcare community.
As the healthcare landscape becomes increasingly digital and performance-driven, mPulse is actively prioritizing platform upgrades to better support its partners, which include 400+ healthcare organizations—including 40 of the country's 50 largest health plans. Decision Point Insights (DPI), mPulse's predictive analytics product, is now integrated with mPulse's omnichannel engagement so that predictive recommendations drive engagement program targeting, and the results of program outreach are visualized in the DPI user interface. This integration allows organizations to orchestrate programs by balancing the needs of consumers and measure program performance in one seamless solution.
mPulse saw immediate interest in these updates with national and regional plans that focus on HEDIS, CAHPS, and HOS performance. These health plans leverage data-driven engagement to better design, launch, and optimize engagement strategies across populations at scale. The result is more coordinated and return on investment (ROI)-focused strategies that improve quality outcomes while delivering better experiences for members at every step of their journey.
Building on recently launched enhancements, customers can now use self-service engagement tools to quickly develop and launch their own interactive omnichannel programs that incorporate mPulse's core natural language understanding (NLU) capabilities. These capabilities are coupled with mPulse's Activator programs that leverage behavioral science and personalization to address specific healthcare business and member needs.
"mPulse is redefining how healthcare organizations engage their consumers and consistently innovating our offerings to ensure our customers have a 360° view of member interactions to streamline operations, reduce costs, save valuable time, and most importantly, improve consumer experience and outcomes,' said Bob Farrell, CEO of mPulse. 'We will continue to be a trusted partner, prioritizing the consumer experience through our HXI products while keeping a pulse on regulations impacting the industry to champion our customer's needs at a macro level.'
The company continues its commitment to meeting the enterprise-level needs of the broader healthcare community, including successfully petitioning the Federal Communications Commission (FCC) to grant a limited waiver of forthcoming amendments to the TCPA rules around consent revocation for members earlier this year. Ahead of the ruling going into effect in April of 2026, mPulse is collaborating with leading healthcare organizations to understand their enterprise engagement and consent management strategies, and developing innovative solutions to support their enterprise goals.
To see how mPulse can support your organization, visit our website here.
About mPulse
mPulse, a leader in digital solutions for the healthcare industry, is transforming consumer experiences to deliver better, more equitable health outcomes. By combining AI-powered analytics, omnichannel outreach and digital health navigation technology, mPulse creates personalized health journeys and provides advanced insights to power collaboration across the healthcare ecosystem. With over a decade of experience and 4 billion consumer touchpoints annually, mPulse is the trusted Health Experience and Insights (HXI) partner for over 400 healthcare organizations. To learn more, visit www.mpulse.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
15 hours ago
- Business Wire
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. ('Abacus' or 'the Company') (NASDAQ: ABL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Abacus is the subject of a report issued by Morpheus Research on June 4, 2025, titled: 'Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue by Systematically Underestimating When People Will Die.' According to the report, the Company changed its portfolio valuation methodology to make it appear more profitable than it actually is. The report also alleges that the Company uses unusual methodologies to calculate life expectancy estimates and its co-founders have 'red flags' in their past. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Yahoo
21 hours ago
- Yahoo
Why EchoStar Corporation (SATS) Soared On Thursday
We recently published a list of . In this article, we are going to take a look at where EchoStar Corporation (NASDAQ:SATS) stands against other best-performing stocks on Thursday. EchoStar rallied for a second day on Thursday, growing 17.47 percent to close at 19.03 apiece, as investors resorted to bargain-hunting while for developments on its ongoing battle with the Federal Communications Commission (FCC). In recent news, FCC announced that it intentionally did not settle worth $326 million of interest payments for one of its senior notes, saying that its ongoing battle with the Federal Communications Commission (FCC) froze its ability to make decisions. A telecom engineer behind the control board in a comms facility. The move sparked concerns among investors about the company's potential filing of bankruptcy protection. In a regulatory filing, EchoStar Corporation (NASDAQ:SATS) said that it received a letter from the FCC on May 9 indicating that the latter was beginning a review of its compliance with certain federal obligations to provide 5G service in the US and raising concerns regarding its buildout extension and mobile-satellite service utilization in the 2GHz band. 'In light of this uncertainty, we have elected not to make an approximately $326 million cash interest payment due on May 30, 2025,' it said, adding that the move was to allow time for the FCC to provide the relief it requested. Overall, SATS ranks 2nd on our list of best-performing stocks on Thursday. While we acknowledge the potential of SATS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@ Sign in to access your portfolio
